Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LYRITUX: Rituximab in Rheumatoid Arthritis
NCT02304354Phase 3Completed
- Sponsor
- University Hospital Tours
- Start
- Mar 2015
- Primary completion
- Apr 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in rheumatoid arthritis (RA), sponsored by University Hospital Tours. Started Mar 2015; status: completed.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02304354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02304354.